Summary In the BUPA Study, a prospective study of 22,000 men attending a screening centre in London, serum samples were collected and stored. The concentration of beta-carotene was measured in the stored serum samples from 271 men who were subsequently notified as having cancer and from 533 unaffected controls, matched for age, smoking history and duration of storage of the serum samples. The mean betacarotene level of the cancer subjects was significantly lower than that of their matched controls (198 and 221 Mg I1 respectively, P=0.007). The difference was apparent in subjects from whom blood was collected several years before the diagnosis of the cancer, indicating that the low beta-carotene levels in the cancer subjects were It has been suggested that beta-carotene (and other carotenoids) may play a role in reducing the incidence of cancer (Peto et al., 1981) . Beta-carotene has anti-oxidant activity (Burton & Ingold, 1984) ; it is an efficient quencher of singlet oxygen (Foote, 1979) . Singlet oxygen is a toxic, and possibly cancer inducing, form of oxygen that occurs as a result of many metabolic reactions.
It has been suggested that beta-carotene (and other carotenoids) may play a role in reducing the incidence of cancer (Peto et al., 1981) . Beta-carotene has anti-oxidant activity (Burton & Ingold, 1984) ; it is an efficient quencher of singlet oxygen (Foote, 1979) . Singlet oxygen is a toxic, and possibly cancer inducing, form of oxygen that occurs as a result of many metabolic reactions. There is limited evidence to suggest that beta-carotene supplementation reduces the risks of chemically induced tumours in animals. Since an important function of carotenoid pigments is to protect organisms from photosensitisation, and hence probably skin cancer which can occur as a result, the administration of beta-carotene to animals is likely to reduce the incidence of skin cancers occurring in those animals. What is, perhaps, of greater interest is whether the administration of beta-carotene can reduce the incidence of cancers that are not induced by ultraviolet light, and in particular of cancers that affect tissues other than skin. Dorogokupla (cited by MathewsRoth, 1982) induced subcutaneous tumours in rats with injections of 9,10-dimethyl-1-2-benzanthracene (DMBA) and skin tumours in mice by the topical application of DMBA; animals fed a diet supplemented with unlimited amounts of red carrots developed tumours at a lower rate than did the animals receiving the unsupplemented diet. Mathews-Roth (1982) administered about 6.7 grams of beta-carotene per kilogram of diet per day to mice and showed that this led to a considerable increase in pigment accumulation in the skin (593 mg 100 g-1 skin) and that the induction of skin tumours by 7,12-dimethylbenzanthracene promoted by croton oil, was inhibited by the stored beta-carotene, there being 3.4 tumours per mouse in the beta-carotene group compared to 11.6 tumours per mouse in the control group (P<0.01). Mathews-Roth used canthaxanthin, a carotenoid without vitamin A activity, as a control substance. It showed no significant anti-cancer activity. Rettura and his colleagues (1982) found that beta-carotene (and retinyl (Stocks, 1958; Bjelke, 1975; Phillips, 1975; MacLennan et al, 1977; Bjelke, 1978; Tuyns et al., 1978; Cook-Mozaffari et al., 1979; Hirayama, 1979; Mettlin et al., 1979; Gregor et al., 1980; Mettlin et al., 1981; Modan et al., 1981; Shekelle et al., 1981; Kvale et al., 1983; Byers et al., 1984; Hinds et al., 1984; Ziegler et al., 1984; Long-De W. et al., 1985; Samet et al., 1985; Stehr et al., 1985; Wu et al., 1985; Pisani et al., 1986; Kolonel et al., 1987) . For lung cancer, the results are clear-cut; the relative risk lying between 1.5 and 2.5 among those with low estimated betacarotene intakes compared with those with a high intake. For cancer of the stomach, large bowel and oesophagus, the relative risk was about 1.5. For cancer of the larynx, bladder and prostate, the relative risk lay between 2 and 3. Most of the studies have been considered in an earlier review (Wald, 1982) ; more recent studies have been generally confirmatory.
Unlike dietary retinol, which is not an important determinant of serum retinol levels in well nourished populations (Willet et al.,1984a; Wald et al., 1985) , dietary beta-carotene has a strong influence on serum beta-carotene levels (Willet et al., 1983) . Since dietary beta-carotene is inversely associated with the risk of cancer, and dietary beta-carotene is associated with serum beta-carotene levels, it follows that one would expect to find an inverse association between serum beta-carotene and the risk of cancer. To see if this was indeed the case, we conducted a prospective study of serum beta-carotene levels in men attending a medical screening centre in London.
Subjects and methods
The design of the prospective study has been described before (Wald et al., 1980 (Wald et al., , 1986 (subjects) . Two controls were selected for each of the subjects, matched on age (within 5 years), duration of storage of the serum sample (within 3 months), smoking habits (current smoker, exsmoker or life-long non-smoker) and, for current smokers, smoking habits -type of product smoked (cigarette, cigar or pipe), amount smoked (within 5 cigarettes per day, 2 cigars per day or an ounce of tobacco per week) and age of starting to smoke (within 5 years). In this way samples from 533 matched controls were identified and analysed. This was 9 less than the 'expected' 542 because serum from some of the cases and controls was spoilt in transport prior to assay; if a case or both controls were so affected all three were omitted but if only one control was so affected the remaining matched case and control were retained in the analysis. The beta-carotene estimations were performed by high pressure liquid chromatography (Vuilleumier et al., 1983) .
Samples were tested in four separate series, two in 1981, one in 1983 and one in 1985. Sera from subjects and their matched controls were always assayed in the same analytical batch without knowledge of whether they were from subjects or from controls. The statistical analysis was based on logarithmically transformed values of beta-carotene, their overall distribution being approximately Gaussian after transformation. All the mean values of beta-carotene presented are transformed back from the logarithmic scale and the standard errors given are approximate. The mean values are adjusted for series, to take account of any changes in assay performance between series, but the (2-sided) p-values given for comparing these means are derived from analyses of variance adjusting for all the variables on which the matching of cases and controls was based. Relative risks were estimated by logistic regression, using the method of Breslow and Day (1980) which takes into account the factors included in the matching. Table I shows the mean serum beta-carotene concentration of subjects and matched controls both overall and classified according to the site of the cancer. The mean beta-carotene concentration for all the cancer subjects was significantly lower than that for their controls (198 and 221 jig -1 respectively, P = 0.007). Following previous practice (Wald et al., 1987) , specific cancer sites were analysed separately if 15 or more men had developed cancer at that site. Stomach cancer (13 subjects) was also considered separately but other sites were grouped together. There was no evidence of a differential effect of beta-carotene according to cancer site (a test for heterogeneity between the seven sites being nonsignificant, P>0.2), but, for some of the sites, the number of cancer subjects available for analysis was small and the possibility of different site-specific effects cannot be excluded. The greatest observed effects were for cancer of the lung and stomach. Table II shows the mean serum beta-carotene of subjects and controls according to the interval between blood collection and diagnosis of cancer and Table III shows, in the same way, the data for lung cancer alone. There was no evidence that the differences in serum beta-carotene between cancer subjects and controls differed for the four periods considered in the two tables. In particular, it appeared that the difference in beta-carotene was present in subjects who had blood collected several years before the diagnosis of cancer. (The mean levels in both cancer subjects and controls decreased with increasing time to diagnosis on account of the concomitant increase in duration of storage of the samples). Table IV shows the number of subjects and controls and relative risks of cancer according to the quintile of serum beta-carotene concentration. There was a statistically significant inverse trend in relative risk (P=0.01); the risk for men in the highest two quintiles of serum beta-carotene was only about 60% of the risk for men in the lowest quintile. Table V , shows in the same way, the data for lung cancer alone.
Results
In the design of our study we matched subjects with controls for age, smoking habits and duration of storage of the serum sample. Mean beta-carotene concentrations classified according to the age of the subject at the time of blood collection showed no consistent pattern (Table VI) . Table VII shows the mean serum beta-carotene levels according to smoking category. Smokers had lower betacarotene levels than non-smokers; the lowest beta-carotene levels tended to occur in the heavier smokers. Table VIII shows the mean beta-carotene levels according to duration of storage of the serum sample. There was a general decline in serum beta-carotene level with increasing storage time; on average the concentration declined by -5% per year. Therefore, in our analysis matching for smoking habits and duration of storage emerged as being important while matching for age less so.
Discussion
We have shown that, as expected from the dietary studies of aRelative risks take into account the matched design of the study and are expressed relative to the risk in the 'all' category. Test for trend: P=0.01. which the association applied though it is of interest that the association was strongest for lung cancer, which is consistent with the prospective dietary studies of beta-carotene intake (Bjelke, 1975; Shekelle et al., 1981; Kvale et al., 1983) .
There are four other published prospective studies of serum beta-carotene or total carotenoids and cancer. These are summarised in beta-carotene concentrations than non-smokers and smoking is also associated with the risk of cancer the mean differences between cancer subjects and controls given for these two studies is likely to over-estimate the differences in beta-carotene that relate, independently of smoking habit, to the risk of cancer. Nonetheless, the results of the two remaining studies in Table IX (Menkes et al., 1986 and the present study) which allowed for smoking habits showed a similar, but less marked, effect. The observation that the inverse association between betacarotene and the risk of cancer persists for several years before the diagnosis of cancer, and does not appear to show a greater effect in those cancer cases for which the time between blood collection and diagnosis was short, indicates that the low beta-carotene level probably precedes the development of cancer. The fact that, in our study, there were only 59 men in whom a diagnosis of cancer was made more than five years after the time of blood collection means that we cannot completely exclude the possibility that early cancer may itself influence serum beta-carotene levels but, taken with the known long-term association between betacarotene consumption and cancer, it is unlikely. The inverse association could arise either directly, because beta-carotene reduces the risk of cancer, or indirectly, because betacarotene intake is associated with the intake of another dietary component that affects the risk of cancer. Which of the two explanations is the correct one should emerge from the results of the large-scale randomised trial of betacarotene supplementation currently in progress among physicians in the United States of America (Hennekens, 1986) . Whatever the answer the association represents a most interesting epidemiological clue to the link between diet and cancer.
